Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s124, 2023. DOI: 10.25251/skin.7.supp.124. Disponível em: https://skin.dermsquared.com/skin/article/view/1952. Acesso em: 17 apr. 2026.